IRADIMED reported third quarter 2026 sales of US$24.2 million and net income of US$6.51 million, alongside confirming a regular US$0.20 per share cash dividend payable on November 27, 2026 to shareholders of record on November 13, 2026. The mix of higher quarterly earnings per share, positive fourth quarter and full year 2026 guidance, and a maintained dividend indicates that IRADIMED is currently balancing product momentum with ongoing cash returns to shareholders. This article will examine...
IRADIMED guidance, earnings and dividend in focus IRADIMED (IRMD) moved into the spotlight after releasing third quarter 2026 results, issuing fresh guidance for the fourth quarter and full year, and reaffirming its regular quarterly dividend. IRADIMED shares trade at $79.42 after a 1 day share price gain of 3.57%. However, the 30 day share price return is down 7% and the year to date share price return has fallen 16.84%. In contrast, the 3 year total shareholder return of 95.93% and 5 year...
Motley Fool Press Release.
This is the newest page. Registered accounts read further back.